InVivo Therapeutics Holdings Corporation
InVivo Therapeutics Holdings Corporation (NVIV) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is InVivo Therapeutics Holdings Corporation (NVIV) stock price today?
As of Feb 12, 2024, 9:00 PM UTC, InVivo Therapeutics Holdings Corporation (NVIV) stock is trading at $0.3207. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date NVIV stock quotes for informed trading decisions.
What is InVivo Therapeutics Holdings Corporation's market capitalization?
InVivo Therapeutics Holdings Corporation (NVIV) has a market capitalization of approximately $995.9K. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare InVivo Therapeutics Holdings Corporation's size relative to other companies in the USD market. The market cap figure updates automatically as the NVIV stock price changes.
What is the 52-week range for InVivo Therapeutics Holdings Corporation stock?
InVivo Therapeutics Holdings Corporation (NVIV) stock has traded in a 52-week range of $0.22 — $2.40. The 52-week range shows the highest and lowest prices at which NVIV traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current InVivo Therapeutics Holdings Corporation stock price to this range provides context for recent price action.
How much trading volume does InVivo Therapeutics Holdings Corporation stock have?
InVivo Therapeutics Holdings Corporation (NVIV) stock recently traded approximately 1.6M shares. Trading volume indicates market liquidity and investor interest in NVIV. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting InVivo Therapeutics Holdings Corporation stock.
Does InVivo Therapeutics Holdings Corporation pay dividends to shareholders?
Yes, InVivo Therapeutics Holdings Corporation (NVIV) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate InVivo Therapeutics Holdings Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is InVivo Therapeutics Holdings Corporation's intraday price range?
Today, InVivo Therapeutics Holdings Corporation (NVIV) stock has traded in a range of $0.301 — $0.409. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring NVIV's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get InVivo Therapeutics Holdings Corporation stock data?
AlphaPilot sources real-time NVIV stock quotes, fundamental financial data, and historical price charts for InVivo Therapeutics Holdings Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The InVivo Therapeutics Holdings Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of NVIV stock performance.